New Horizon Health, a Chinese early-stage cancer screening developer, has secured $66 million in a series C funding round while medical device e-commerce platform LyncMed has raised $20 million in a series B+1 round.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
